FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W93877611> ?p ?o ?g. }

• W93877611 endingPage "287" @default.
• W93877611 startingPage "277" @default.
• W93877611 abstract "Treatment of breast cancer in the adjuvant setting has changed rapidly over the last few years. In addition to improvements in chemotherapy, radiation, hormone manipulation, and surgery, immunotherapy has emerged as an effective adjunct for the treatment of breast cancer. Passive immunotherapeutic agents such as trastuzumab have been widely adopted as the standard of care for HER-2/neu overexpressing breast cancer. Vaccine therapy in the metastatic setting has yet to demonstrate clinical significance in a phase III testing. This may be due to the enhanced immunosuppressive effects demonstrated in the tumor microenvironment. Lack of co-stimulatory molecules, activation of the cytotoxic T-lymphocyte antigen-4 (CTLA-4), increased T regulatory cells as well as soluble immunosuppressive factors produced by the tumor contribute to the ineffectiveness of vaccine therapy. Based on these observations, there has been a shift towards treating patients with minimal residual disease and a high risk of relapse. In this adjuvant setting, immune mechanisms of tumor evasion are less formidable, and the use of vaccine therapy in these patients may offer a higher chance of clinical benefit. There are several different vaccine approaches, including the use of cell-based vaccines (autologous, allogeneic, or dendritic cell-based), tumor-associated peptide or protein vaccines, DNA vaccines, heat shock proteins, and recombinant technology using viral or bacterial vectors to enhance immunogenicity of vaccine preparations. This review summarizes principles involving vaccine formulation and antigen selection, followed by a brief synopsis of therapeutic vaccines given in the metastatic setting and possible reasons for their lack of efficacy. The current literature regarding vaccine development for the treatment of breast cancer in the adjuvant setting is also reviewed." @default.
• W93877611 created "2016-06-24" @default.
• W93877611 creator A5024613613 @default.
• W93877611 creator A5044161354 @default.
• W93877611 creator A5066061720 @default.
• W93877611 creator A5066190550 @default.
• W93877611 creator A5077026571 @default.
• W93877611 date "2009-10-01" @default.
• W93877611 modified "2023-10-13" @default.
• W93877611 title "Therapeutic Breast Cancer Vaccines" @default.
• W93877611 cites W1512392935 @default.
• W93877611 cites W1541668845 @default.
• W93877611 cites W1820106848 @default.
• W93877611 cites W1939610331 @default.
• W93877611 cites W1943191147 @default.
• W93877611 cites W1960833366 @default.
• W93877611 cites W1968243011 @default.
• W93877611 cites W1973254558 @default.
• W93877611 cites W1979397217 @default.
• W93877611 cites W1985855758 @default.
• W93877611 cites W1988511213 @default.
• W93877611 cites W1993115059 @default.
• W93877611 cites W1999589493 @default.
• W93877611 cites W2004228980 @default.
• W93877611 cites W2009648532 @default.
• W93877611 cites W2010158364 @default.
• W93877611 cites W2011243140 @default.
• W93877611 cites W2023519138 @default.
• W93877611 cites W2024167344 @default.
• W93877611 cites W2026470830 @default.
• W93877611 cites W2029421056 @default.
• W93877611 cites W2031745114 @default.
• W93877611 cites W2035144728 @default.
• W93877611 cites W2042421888 @default.
• W93877611 cites W2051289826 @default.
• W93877611 cites W2059361896 @default.
• W93877611 cites W2060693328 @default.
• W93877611 cites W2067108808 @default.
• W93877611 cites W2067267566 @default.
• W93877611 cites W2068971398 @default.
• W93877611 cites W2069175547 @default.
• W93877611 cites W2076759296 @default.
• W93877611 cites W2101030466 @default.
• W93877611 cites W2104599421 @default.
• W93877611 cites W2105871790 @default.
• W93877611 cites W2113313714 @default.
• W93877611 cites W2115241901 @default.
• W93877611 cites W2116407378 @default.
• W93877611 cites W2120887760 @default.
• W93877611 cites W2121498145 @default.
• W93877611 cites W2129817669 @default.
• W93877611 cites W2137049683 @default.
• W93877611 cites W2146203443 @default.
• W93877611 cites W2146384083 @default.
• W93877611 cites W2146674901 @default.
• W93877611 cites W2148177811 @default.
• W93877611 cites W2149647856 @default.
• W93877611 cites W2149908785 @default.
• W93877611 cites W2156106286 @default.
• W93877611 cites W2158590345 @default.
• W93877611 cites W2162234205 @default.
• W93877611 cites W2163406401 @default.
• W93877611 cites W2164907614 @default.
• W93877611 cites W2221724330 @default.
• W93877611 cites W2257223004 @default.
• W93877611 cites W2318605753 @default.
• W93877611 cites W2324215405 @default.
• W93877611 cites W2333334969 @default.
• W93877611 cites W2409239642 @default.
• W93877611 cites W2591201173 @default.
• W93877611 cites W3098140345 @default.
• W93877611 cites W4232529261 @default.
• W93877611 cites W4361867966 @default.
• W93877611 doi "https://doi.org/10.2165/11313490-000000000-00000" @default.
• W93877611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19754218" @default.
• W93877611 hasPublicationYear "2009" @default.
• W93877611 type Work @default.
• W93877611 sameAs 93877611 @default.
• W93877611 citedByCount "30" @default.
• W93877611 countsByYear W938776112012 @default.
• W93877611 countsByYear W938776112014 @default.
• W93877611 countsByYear W938776112016 @default.
• W93877611 countsByYear W938776112017 @default.
• W93877611 countsByYear W938776112018 @default.
• W93877611 countsByYear W938776112019 @default.
• W93877611 countsByYear W938776112020 @default.
• W93877611 countsByYear W938776112022 @default.
• W93877611 countsByYear W938776112023 @default.
• W93877611 crossrefType "journal-article" @default.
• W93877611 hasAuthorship W93877611A5024613613 @default.
• W93877611 hasAuthorship W93877611A5044161354 @default.
• W93877611 hasAuthorship W93877611A5066061720 @default.
• W93877611 hasAuthorship W93877611A5066190550 @default.
• W93877611 hasAuthorship W93877611A5077026571 @default.
• W93877611 hasBestOaLocation W938776111 @default.
• W93877611 hasConcept C121608353 @default.
• W93877611 hasConcept C126322002 @default.
• W93877611 hasConcept C143998085 @default.

• next